Research graph
References from An update on the management of uterine fibroids: personalized medicine or guidelines?. Local targets link to admitted publications; unresolved targets remain external evidence.
Proceedings from the national institute of child health and human development conference on the uterine fibroid research update workshop
10.1016/j.fertnstert.2010.08.049 · 2011 · External reference
The estimated annual cost of uterine leiomyomata in the United States
10.1016/j.ajog.2011.12.002 · 2012 · External reference
Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment
10.1210/endrev/bnab039 · 2022 · External reference
Epidemiology and risk factors of uterine fibroids
10.1016/j.bpobgyn.2017.09.004 · 2018 · External reference
The epidemiology and genetics of uterine leiomyoma
10.1016/j.bpobgyn.2015.11.018 · 2016 · External reference
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
10.1038/ng849 · 2002 · External reference
MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas
10.1126/science.1208930 · 2011 · External reference
MED12 mutation frequency in unselected sporadic uterine leiomyomas
10.1016/j.fertnstert.2014.06.040 · 2014 · External reference
Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma
10.1371/journal.pone.0033284 · 2012 · External reference
DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma
10.1016/s0090-8258(03)00194-x · 2003 · External reference
Progesterone is essential for maintenance and growth of uterine leiomyoma
10.1210/en.2009-1225 · 2010 · External reference
Uterine leiomyoma stem cells: linking progesterone to growth
10.1055/s-0035-1558451 · 2015 · External reference
Uterine fibroids
10.1056/nejmra1209993 · 2013 · External reference
Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment
10.1210/endrev/bnab039 · 2022 · External reference
FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age
10.1016/j.ijgo.2010.11.011 · 2011 · External reference
Clinical limitations of the International Federation of Gynecology and Obstetrics (FIGO) classification of uterine fibroids
10.1002/ijgo.12266 · 2017 · External reference
Terms, definitions and measurements to describe Sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group
10.1002/uog.14806 · 2015 · External reference
Feasibility of a new system of classification of submucous myomas: a multicenter study
10.1016/j.fertnstert.2011.01.147 · 2011 · External reference
Fibroid vascularisation assessed with three-dimensional power Doppler ultrasound is a predictor for uterine fibroid growth: a prospective cohort study
10.1111/1471-0528.14608 · 2018 · External reference
Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas
10.1067/mob.2002.121725 · 2002 · External reference
Diagnostic accuracy of MRI in the differential diagnosis between uterine leiomyomas and sarcomas: a systematic review and meta-analysis
2023 · External reference
Accuracy of saline contrast sonohysterography in detection of endometrial polyps and submucosal leiomyomas in women of reproductive age with abnormal uterine bleeding: systematic review and meta-analysis
10.1002/uog.17352 · 2017 · External reference
Real-time elastography for assessment of uterine disorders
10.1002/uog.12519 · 2014 · External reference
Contrast-enhanced ultrasound imaging of uterine disorders: a systematic review
10.1177/01617346211017462 · 2021 · External reference
Management of Symptomatic Uterine Leiomyomas: ACOG Practice Bulletin, Number 228
10.1097/aog.0000000000004401 · 2021 · External reference
Epidemiology of uterine fibroids: a systematic review
10.1111/1471-0528.14640 · 2017 · External reference
10.1016/j.jeud.2023.100018 · 2023 · Admitted local publication
Evidence-based approach for secondary prevention of uterine fibroids (The ESCAPE Approach)
10.3390/ijms242115972 · 2023 · External reference
Blood vessels of the intratumoral septa in uterine leiomyomata
2013 · External reference
Endometrial angiogenesis of abnormal uterine bleeding and infertility in patients with uterine fibroids-A systematic review
10.3390/ijms24087011 · 2023 · External reference
Fibroid vascularisation assessed with 3D Power Doppler as predictor for fibroid related symptoms and quality of life; a pilot study
10.52054/fvvo.13.4.044 · 2021 · External reference
From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health
10.1016/j.fertnstert.2022.07.021 · 2022 · External reference
Menstrual Distress Questionnaire (MEDI-Q): a new tool to assess menstruation-related distress
10.1016/j.rbmo.2021.08.029 · 2021 · External reference
Uterine fibroids, perceived stress, and menstrual distress: a key role of heavy menstrual bleeding
10.1007/s43032-022-01126-3 · 2023 · External reference
Uterine fibroids
10.1038/nrdp.2016.43 · 2016 · External reference
Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis
2022 · External reference
Unresolved reference
2017 · External reference
Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids
10.2217/whe.13.28 · 2013 · External reference
Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas
10.1016/s0015-0282(03)00175-4 · 2003 · External reference
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
2020 · External reference
Intrauterine device use among women with uterine fibroids: a systematic review
10.1016/j.contraception.2010.02.011 · 2010 · External reference
In vivo mechanisms of uterine myoma volume reduction with ulipristal acetate treatment
10.1016/j.fertnstert.2015.04.025 · 2015 · External reference
Long-term treatment of uterine fibroids with ulipristal acetate
10.1016/j.fertnstert.2014.02.008 · 2014 · External reference
Ulipristal acetate versus leuprolide acetate for uterine fibroids
10.1056/nejmoa1103180 · 2012 · External reference
Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo
10.1093/humrep/det467 · 2014 · External reference
Selective progesterone receptor modulators (SPRMs) for uterine fibroids
10.1002/14651858.cd010770.pub2 · 2017 · External reference
Efficacy and safety of vilaprisan in women with uterine fibroids: data from the ASTEROID 3 randomized controlled trial
2023 · External reference
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
10.2147/ijwh.s65481 · 2014 · External reference
Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial
10.1093/humrep/der224 · 2011 · External reference
Effective treatment of heavy menstrual bleeding with estradiol valerate and dienogest: a randomized controlled trial
10.1097/aog.0b013e3182118ac3 · 2011 · External reference
Combined oral contraceptive for treatment of women with uterine fibroids and abnormal uterine bleeding: a systematic review
10.1159/000369390 · 2015 · External reference
Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
10.1016/s0140-6736(22)01475-1 · 2022 · External reference
Treatment of uterine fibroid symptoms with relugolix combination therapy
10.1056/nejmoa2008283 · 2021 · External reference
Elagolix for heavy menstrual bleeding in women with uterine fibroids
10.1056/nejmoa1904351 · 2020 · External reference
Elagolix treatment for up to 12 months in women with heavy menstrual bleeding and uterine leiomyomas
10.1097/aog.0000000000003869 · 2020 · External reference
What we know about the long-term risks of hysterectomy for Benign Indication-A Systematic Review
10.3390/jcm10225335 · 2021 · External reference
Short-term quality of life after myomectomy for uterine Fibroids from the COMPARE-UF Fibroid Registry
10.1016/j.ajog.2019.09.052 · 2020 · External reference
Comparative effectiveness of hysterectomy versus myomectomy on one year health-related quality of life in women with uterine fibroids
10.1016/j.fertnstert.2019.10.028 · 2020 · External reference
Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids
10.1016/j.ajog.2023.05.020 · 2023 · External reference
Recurrence of uterine fibroids after conservative surgery or radiological procedures: a narrative review
2023 · External reference
Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results
10.1111/j.1471-0528.2011.02952.x · 2011 · External reference
Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial
10.1016/j.ajog.2016.06.051 · 2016 · External reference
Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis
10.1016/j.ejogrb.2014.03.009 · 2014 · External reference
Fibroids and natural fertility: a systematic review and meta-analysis
10.1016/j.rbmo.2021.03.013 · 2021 · External reference
The impact of FIGO type 3 fibroids on in-vitro fertilization outcomes: a nested retrospective case-control study
10.1016/j.ejogrb.2019.12.018 · 2020 · External reference
Fibroids and infertility: an updated systematic review of the evidence
10.1016/j.fertnstert.2008.01.051 · 2009 · External reference
Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
2018 · External reference
Surgical treatment of fibroids for subfertility
2020 · External reference
Intramural myomas more than 3-4 centimeters should be surgically removed before in vitro fertilization
10.1016/j.fertnstert.2021.08.016 · 2021 · External reference
The effect of intramural fibroids without uterine cavity involvement on the outcome of IVF treatment: a systematic review and meta-analysis
10.1093/humrep/dep396 · 2010 · External reference
Intramural myomas-related infertility: should the myomas be removed? Not easy to reach a consensus
10.1016/j.fertnstert.2021.08.015 · 2021 · External reference
First series of 18 pregnancies after ulipristal acetate treatment for uterine fibroids
10.1016/j.fertnstert.2014.07.1253 · 2014 · External reference
Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis
10.1093/humupd/dmz012 · 2019 · External reference
Uterine fibroid management: from the present to the future
10.1093/humupd/dmw023 · 2016 · External reference
Presence of adenomyosis at MRI reduces live birth rates in ART cycles for endometriosis
10.1093/humrep/deac083 · 2022 · External reference
Focal adenomyosis of the outer myometrium and deep infiltrating endometriosis severity
10.1016/j.fertnstert.2020.05.003 · 2020 · External reference
Uterine leiomyoma is associated with the risk of developing endometriosis: a nationwide cohort study involving 156,195 women
10.1371/journal.pone.0256772 · 2021 · External reference
Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities
10.1093/humupd/dmad009 · 2023 · External reference
Genome-wide association and epidemiological analyses reveal common genetic origins between uterine leiomyomata and endometriosis
10.1038/s41467-019-12536-4 · 2019 · External reference
Ultrasound findings in infertile women with endometriosis: evidence of concomitant uterine disorders
10.1080/09513590.2020.1736027 · 2020 · External reference
Diagnosing adenomyosis: an integrated clinical and imaging approach
10.1093/humupd/dmz049 · 2020 · External reference
Quantitative measurements of menstrual blood loss in ovulatory and anovulatory cycles in middle- and late-reproductive age and the menopausal transition
10.1097/aog.0b013e3181ca4b3a · 2010 · External reference
Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis
10.2147/ijwh.s133212 · 2017 · External reference
Variation of the human menstrual cycle through reproductive life
1967 · External reference
10.1016/j.jeud.2023.100018 · 2023 · Admitted local publication
Automated uterine fibroids detection in ultrasound images using deep convolutional neural networks
10.3390/healthcare11101493 · 2023 · External reference
Revolutionizing hysteroscopy outcomes: AI-powered uterine myoma diagnosis algorithm shortens operation time and reduces blood loss
10.3389/fonc.2023.1325179 · 2023 · External reference
